Cadonilimab Combined With RT in LACC Patients Ineligible for CCRT

Clinical trial NCT07450963 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07450963
Sponsor: Ruijin Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Locally Advanced Cervical Cancer

Start date: 2026-03-01
Primary completion: 2029-02-01
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.